Engaging outside experts in patent review could curtail the granting of unmerited patents, which can lead to high prices for essential drugs in resource-poor countries.
Engaging outside experts in patent review could curtail the granting of unmerited patents, which can lead to high prices for essential drugs in resource-poor countries.
Partner with us now to build
a more just and equitable
medicine system for all.